Bausch Health Companies Inc vs. Eli Lilly & Co.
Eli Lilly & Co. (LLY) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| BHC | LLY | |
|---|---|---|
| Market Cap | $2.13 billion | $1.05 trillion |
| Revenue (TTM) | $10.85 billion | $79.67 billion |
| Net Income (TTM) | $-1,093,000,000 | $26.71 billion |
LLY leads on 3 of 3 size & scale factors.
Valuation
| BHC | LLY | |
|---|---|---|
| P/E Ratio | — | 39.77 |
| Price / Book | -2.65 | 31.14 |
| Price / Sales | 0.20 | 13.24 |
BHC leads on 2 of 2 valuation factors.
Profitability
| BHC | LLY | |
|---|---|---|
| Net Margin | -10.07% | 33.53% |
| Return on Equity | 136.28% | 78.84% |
BHC and LLY split the profitability factors evenly.
Dividend
| BHC | LLY | |
|---|---|---|
| Dividend Yield | — | 0.58% |
| Payout Ratio | — | 23.23 |
BHC and LLY split the dividend factors evenly.
Risk & Sentiment
| BHC | LLY | |
|---|---|---|
| Short Interest | 3.80% | 1.29% |
LLY leads on 1 of 1 risk & sentiment factors.
Dig deeper: BHC overview, BHC financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.